[18F]MK-0947
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]MK-0947, covering 2026-01-16 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease [EARLY_Phase 1]